Recent research shows that patients with rheumatoid arthritis (RA) are more likely to follow a simple drug therapy program, such as methotrexate (MTX) plus a tumor necrosis factor inhibitor (TNFi), than follow a “triple-therapy” regimen of MTX, hydroxychloroquine, and sulfasalazine, according to a recent study published in Arthritis Care & …
Read More